Want to create an interactive transcript for this episode?
Podcast: Pharmacy Podcast Network
Episode: TWIRx | Treating Gram-Negative Bacterial Infections with Thomas Lodise, PharmD, PhD
Description:
A new, real-world evidence study of patients with Gram-negative infections showed that early intervention with Fetroja® (cefiderocol) significantly reduced in-hospital all-cause mortality. This real-world evidence, drawn from a retrospective analysis of 275 seriously ill patients, emphasizes the critical importance of timely treatment.Â
Â
The retrospective multicenter observational study showed earlier treatment resulted in a reduction in in-hospital all-cause mortality (IHACM) in patients with Gram-negative infections who previously received other antibiotics, including those with difficult-to-treat pathogens that were resistant to other antibiotics.
Â
Here is a link to the press release with a summary of the results presented by Shionogi at ID Week in Octobe...